# Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)

> **NCT01856855** · NA · COMPLETED · sponsor: **John Fiveash, MD** · enrollment: 26 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Radiation Toxicity
- Sexual Dysfunction

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy with Integrated Boost

## Key facts

- **NCT ID:** NCT01856855
- **Lead sponsor:** John Fiveash, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856855, "Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01856855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*